Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0200329 COMPOSITION FOR USE IN PROMOTING WOUND HEALING
A pharmaceutical composition for use in promoting wound healing and/or accelerating closure of an open wound in a subject in need thereof is disclosed. The...
2018/0200328 PD-1 Peptide Inhibitors
This disclosure provides peptides which have a strong affinity for the checkpoint receptor "programmed death 1" (PD-1). These peptides block the interaction of...
2018/0200327 METHOD OF TREATING LOW BLOOD PRESSURE
A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but...
2018/0200326 ANG-(1-7) AND DERIVATIVE OLIGOPEPTIDES FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY AND OTHER COGNITIVE IMPAIRMENTS
The present invention provides oligopeptides, in particular, Ang-(1-7) derivatives, and methods for using and producing the same. In one particular embodiment,...
2018/0200325 STABILIZED PEPTIDE COMPOSITION
Provided herein is a peptide composition that is highly stable and can be stored long term, said composition containing one or more types of peptides having an...
2018/0200324 ARTIFICIAL PEPTIDES AND USE THEREOF FOR GLYCOGEN STORAGE DISORDERS
The present invention discloses a peptide capable of stabilizing mutation-induced GBE1 protein destabilization, conjugates comprising same and uses thereof for...
2018/0200323 USE OF TETRAPEPTIDE -3 GEKG OR PENTAPEPTIDE -3 GEKGF FOR TREATING DEGENERATIVE JOINT DISEASE
Use of tetrapeptide-3 GEKG or pentapeptide-3 GEKGF for treating degenerative joint disease is disclosed. A pharmaceutical composition comprising an effective...
2018/0200322 Arthritis Relief and Remedy Method
A method for relieving the symptoms of arthritis externally is described. The method involves the use of sliced ginger root, moxa, produced from mugwort, and a...
2018/0200321 COMPOSITIONS COMPRISING PHOENIX DACTYLIFERA AND METHODS OF PREVENTION AND TREATMENT USING THEREOF
The present invention relates to compositions comprising: Phoenix dactylifera fruit flesh; or Phoenix dactylifera fruit skin; or Phoenix dactylifera fruit...
2018/0200320 METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS, CANCER, PAIN,...
The present disclosure relates generally to the preparation and use of certain botanical extracts and therapeutic compositions for the treatment of viral...
2018/0200319 METHOD OF CHINESE HERBAL MEDICINE EXTRACT USED FOR TREATING MULTIPLE DISEASES CAUSED BY DRUG RESISTANT BACTERIA...
Disclosed is a new drug application of a Pithecellobium Clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple...
2018/0200318 USE OF MANGOSTEEN RIND EXTRACT IN PREPARATION OF MEDICINE FOR TREATING SKIN DISEASES
Use of a composition in preparation of medicine for treating skin diseases, the composition comprising an effective dose of mangosteen rind extract.
2018/0200317 METHOD FOR TREATING FATTY LIVER
A method of treating fatty liver comprising administering an effective amount of a plant belonging to a genus Cirsium to a patient in need of the treatment.
2018/0200316 Composition for the treatment of neurobehavioral disorders
The invention relates to a composition for use in the treatment of neurobehavioral disorders, a Cannabis plant extract comprising Cannabinol preferably with...
2018/0200315 CANNABINOID AND CAFFEINE EMULSIFICATIONS
A cannabinoid emulsification comprising at least one emulsifying agent; an aqueous vehicle; a base oil; cannabis oil; and caffeine; wherein the cannabinoid...
2018/0200314 EUGLENA DERIVED COMPOSITION HAVING BIOMASS AND IMMUNE RESPONSE INDUCING COMPONENTS
A composition includes a Euglena whole cell biomass and cellular components, including beta-1,3-glucan as at least about 90 percent linear, unbranched...
2018/0200313 Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals
The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been...
2018/0200312 Methods and Compositions for Enhancing Memory and/or Reducing Fear and/or Pain of a Host by Administering a...
The present invention provides for a probiotic composition designed to enhance memory and/or reduce fear and/or pain of a host, the probiotic composition...
2018/0200311 BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS
This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products,...
2018/0200310 COMPOSITIONS AND METHODS
Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of...
2018/0200309 ANTIBIOTIC SENSITIVE BACILLUS STRAINS HAVING ANTIMICROBIAL EFFECT AGAINST E. COLI AND CLOSTRIDIUM PERFRINGENS...
A Bacillus strain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline...
2018/0200308 METHODS OF TREATING COLITIS
Provided are methods of treating a colitis using a microbial composition and antibiotic.
2018/0200307 COMPOSITIONS COMPRISING BACTERIAL STRAINS
The invention provides compositions comprising one or more bacterial strains for use in a method of reducing the level of Enterobacteriaceae in the...
2018/0200306 CURED GEL AND METHOD OF MAKING
A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at...
2018/0200305 Isolated Populations of Female Germline Stem Cells and Cell Preparations and Compositions Thereof
The present invention relates to female germline stem cells and their progenitors, methods of isolation thereof, and methods of use thereof.
2018/0200304 SPALAX FIBROBLAST-DERIVED ANTI-CANCER AGENTS
A conditioned cell culture medium of cells derived from Spalax or naked mole rat (Heterocephalus glaber) and methods for preparing it are provided....
2018/0200303 ISOLATION OF HUMAN NEURAL STEM CELLS FROM AMNIOTIC FLUID OF PATIENTS WITH NEURAL TUBE DEFECTS
The present invention provides a method for isolating human neural stem cells from amniotic fluid of a patient whose fetus has been diagnosed to have a neural...
2018/0200302 BONE MARROW STROMAL CELL DERIVED EXTRACELLULAR MATRIX PROTEIN EXTRACT AND USES THEREOF
Disclosed are bone marrow stromal cell derived extracellular matrix protein extracts that are useful for the expansion and proliferation of mesenchymal stem...
2018/0200301 Low-Oxygen-Treated Mesenchymal Stem Cell and Use Thereof
The present invention relates to a hypoxia-treated mesenchymal stem cell and the use thereof. The present invention discloses for the first time that treating...
2018/0200300 METHODS OF TRANSPLANTATION AND DISEASE TREATMENT
A method of transplantation is disclosed. The method comprising administering to a subject in need of transplantation of cells in suspension, a therapeutically...
2018/0200299 POLYCLONAL GAMMA DELTA T CELLS FOR IMMUNOTHERAPY
Provided herein is a method of expanding clinically-relevant quantities of polyclonal .gamma..delta. T cells that have anti-tumor, anti-viral, and...
2018/0200298 METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
The present invention provides nucleic acids, vectors, host cells, methods and compositions to confer and/or augment immune responses mediated by cellular...
2018/0200297 COMPOSITION COMPRISING CARNITINE, SODIUM CHOLATE, SODIUM ACETATE AND OPTIONALLY SILVER FOR USE IN THE TREATMENT...
Disclosed is a composition comprising: a) carnitine, b) sodium cholate, c) sodium acetate, and optionally d) silver, for use in the treatment of psoriasis,...
2018/0200296 Magnetic Nanoaggregate-Embedded Bead, Manufacturing Method Thereof and Bioparticle Detection Method Using the Same
A magnetic nanoaggregate-embedded bead (NAEB), a manufacturing method thereof and a bioparticle detection method using the same are disclosed. The magnetic...
2018/0200295 IN SITU PREPARATION OF CYANO-BRIDGED METAL NANOPARTICLES WITHIN A BIOCOMPATIBLE REVERSE MICELLAR SYSTEM
The present invention relates to a method for in situ preparation of cyano-bridged coordination polymers as metal nanoparticles within a biocompatible reverse...
2018/0200294 TREATING ROTATOR CUFF CONDITIONS
This document provides methods and materials related to treating rotator cuff conditions (e.g., rotator cuff tendonitis or rotator cuff injuries such as...
2018/0200293 STABILIZED GOLD NANOPARTICLES
The present disclosure relates to gold nanoparticles stabilized with benzylalkyl(C8-C18) ammonium chloride, and methods and uses comprising the same.
2018/0200292 COMPOSITIONS AND METHODS FOR OBTAINING AN IMPROVED LUNG FUNCTION
A pharmaceutical composition for obtaining an improved lung function in a human or an animal lung affected by airway obstruction such as COPD or asthma, is...
2018/0200291 COMPOSITIONS COMPRISING A ZEOLITE AND USE THEREOF FOR THE TREATMENT OF TRIMETHYLAMINURIA
Provided herein are methods of treating trimethylaminuria in a subject by administering a composition including a zeolite.
2018/0200290 COMPOSITIONS COMPRISING A ZEOLITE AND USE THEREOF FOR THE TREATMENT OF SLEEP DISORDERS
Provided herein are compositions including a zeolite and methods of treating a sleep disorder in a subject by administering these compositions. For example,...
2018/0200289 NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE
Described are stable topical formulations useful in the treatment of viral infection, demodex infection, fungal infection and bacterial infection of the eye,...
2018/0200288 POLYMERIC TREATMENT COMPOSITIONS
Compositions are described comprising a polymer; a non-physiological pH solution; and a visualization agent; wherein the polymer is soluble in the...
2018/0200287 PECTIN BASED NANOPARTICLES
This invention provides (a) nanoparticle made of: sugar-beet pectin; and a bioactive compound (such as a nutraceutical or a drug) bound to sugar-beet pectin....
2018/0200286 METHODS AND COMPOSITIONS FOR TREATING WOUNDS UTILIZING CHITOSAN COMPOUNDS
Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or...
2018/0200285 DIETARY PREBIOTIC SUPPLEMENT AND RELATED METHOD
A composition and a method for improving the gastrointestinal (GI) health of a human subject by promoting the activity of amylolytic and short-chain fatty acid...
2018/0200284 Multi-functional Composition and Preparation Method and Application Thereof
A multi-functional composition is disclosed as well as the preparation method and applications thereof. The composition contains a marine algae-derived...
2018/0200283 PHARMACEUTICAL COMPOSITION FOR INHIBITING RESISTANCE AGAINST ANTICANCER DRUGS OF PATIENT SUFFERING FROM OVARIAN...
A pharmaceutical composition includes an NAG-1 inhibitor as an active ingredient for inhibiting resistance against an anticancer drug of an ovarian cancer...
2018/0200282 2'-METHOXY SUBSTITUTED OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATIONS
Compositions comprising first and second oligomers are provided wherein at least a portion of the first oligomer is capable of hybridizing with at least a...
2018/0200281 CONTROL OF COLEOPTERAN PESTS USING RNA MOLECULES
Disclosed are double stranded RNA molecules that are toxic to coleopteran insects. In particular, interfering RNA molecules capable of interfering with pest...
2018/0200280 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
Cytidine nucleoside analogues of Formula I, wherein the variables are as described herein, in combination with uridine nucleoside analogues of Formula II,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.